Pathstone Holdings »

Athira Pharma shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 492k 2.65
2024-03-31 $1.3M 492k 2.74
2023-12-31 $905k 372k 2.43

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Simplify Asset Management
Daniel D. Thurber
Tang Capital Management
BML Capital Management
BlackRock
Dimensional Fund Advisors
Jacobs Levy Equity Management
Pathstone Holdings
Two Sigma Advisers
Bristlecone Advisors
Acadian Asset Management

View all funds holding Athira Pharma